Long-lasting treatment suppresses HIV in people with mental illness and other conditions that make it challenging to adhere to standard treatments.

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low UK law firms are considering legal action on behalf of women who developed ...

After a reckless shopping spree, I ditched contactless payments and bank cards to see how far £200 cash in hand would get me – and if I could improve my spending habits If I’m lucky, I can just about ...

With 2026 now in full swing, many are turning their attention to GLP-1 weight-loss medications like Mounjaro, either having started treatment or seriously considering it. However, a prominent expert ...

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...

Novo Nordisk is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. The move escalates the ...

More people in affluent areas are using weight loss jabs, despite having lower levels of obesity, research suggests. Analysis of private prescriptions for GLP-1 drugs like Mounjaro and Wegovy shows ...

Leqvio (inclisiran) may cause injection site reactions, including bruising, pain, discoloration, itchiness, and a burning or prickling sensation at the injection site. In addition to injection site ...